Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children’s Hospital report today in PLOS ONE. The study highlights gaps in how the long-term safety of drugs intended for chronic use in children is assessed as part of the FDA approval…Read More
UNLIMITED Cheap CEUs for One Low Price!
- Repeated head impacts associated with later-life depression symptoms, worse cognitive function June 29, 2020
- New Study Sees Unprecedented Trauma from the Pandemic June 25, 2020
- Does Bedtime Media Use Harm Children’s Sleep? Only if They Struggle to Self-Regulate Behavior June 24, 2020
- Pioneers, Mentors, and Diversity in Animal Behavior Science June 23, 2020
- Who Uses Drugs and Why? June 22, 2020